Rigid monoclonal antibodies improve detection of SARS-CoV-2 nucleocapsid protein

Mostrar otras versiones (1)

Monoclonal antibodies (mAbs) are the basis of treatments and diagnostics for pathogens and other biological phenomena. We conducted a structural characterization of mAbs against the N-terminal domain of nucleocapsid protein (NP(NTD)) from SARS-CoV-2 using small-angle X-ray scattering and transmissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodge, Curtis D., Rosenberg, Daniel. J., Grob, Patricia, Wilamowski, Mateusz, Joachimiak, Andrzej, Hura, Greg L., Hammel, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043170/
https://www.ncbi.nlm.nih.gov/pubmed/33843452
http://dx.doi.org/10.1080/19420862.2021.1905978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043170/
https://www.ncbi.nlm.nih.gov/pubmed/33843452
http://dx.doi.org/10.1080/19420862.2021.1905978

Ejemplares similares